We have completed our first Robotic Retroperitoneal Lymph Node Dissection @Austin_Health. Patients potentially only need to stay overnight. Again we are thankful to have the Da Vinci Xi robotic system. Thank you Prof. Lawrentschuk’s proctoring and Prof. Damien Bolton’s support.

🚨Neurosafe RCT(n=407) at gamechanger sess by Greg Shaw #EAU25. In men with good baseline erections having RALP, 12 mth erectile function better with neurosafe technique vs SOC (IIEF 12.7vs9.7, p<0.001) & early continence better. Published @TheLancetOncol https://t.co/gCfwIhCs1N

Cancer Statistics 2025 are out! #prostatecancer incidence still on the rise, mortality basically flat. Get screened so you can get treatment _when needed_. #pcsm https://t.co/CS7SKz6Tuc

Gone too soon. Vale Brian.

Out now: Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival in @BJUIjournal by Manon Vreeburg and Oscar Brouwer #publicationoftheweek ⬇️ https://t.co/CVLEwnrP63

1/4 Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial - ScienceDirect.

Remembering Christchurch | a GU Cast Special. We put together this one hour video podcast to remember the devastating 2011 Christchurch Earthquake and explain why it matters to @USANZUrology @gu_onc Some amazing stories in there

STOPCAP meta-analysis: Docetaxel addition to ADT ➡️ limited OS/PFS benefit in low-volume metachronous mCSPC ➡️ best suited for high volume/potentially bulky/T4 primary tumors @ChrisSweens1 @BertrandTOMBAL @pgd81 @mattsydes @Prof_Nick_James https://t.co/S3PJ6FfJbJ #ProstateCancer

Cost-effectiveness of systemic treatment intensification in men with metastatic hormone-sensitive #ProstateCancer. Presented by @NiranjanJS @USANZUrology. #AUA23 written coverage by @rksayyid @UofT > https://t.co/Y7wnWSMuSS @AmerUrological

Diagnostic Accuracy of PSMA PET/CT for Initial Staging of Intermediate to High-risk Prostate Cancer: Systematic Review and Meta-analysis "PSMA-PET should be used as a first-line approach for the initial staging of PCa." https://t.co/C7BTHRIoky @EUplatinum @declangmurphy

🎯After 21 yrs in Rotterdam PCa screening study: Invite 246, diagnose 14 to prevent 1 death. Invite 121, diagnose 7 to prevent 1 metastatic case. Overdiagnosis now strongly reduced (risk stratification, MRI etc). Let's bring this advantage to all men who may benefit! @uroweb

Thanks to @NeuroAhmad for this critical piece on limited global diversity of Cochrane Urology authorship @BJUIjournal; more work to do @VikramNarayan @GiuliaILane @NiranjanJS @DraganIlic99 @onuralp_ergun @EBMUrology @juan_francomd @drimranomar

@JonathanSOBrien & @declangmurphy deliver one of highest quality videos of #EAU23 with slick, professional production values. This is how all videos should be put together! If only rest of our community had skills of this group. Key message: RP is safe/feasible after #Lutectomy

Cutting edge presentation on the use of ICG during robotic ILND @JonathanSOBrien @lawrentschuk @gu_onc. Super slick AV @declangmurphy #EAU23

Great slide on factors to predict surgical outcome for LUTS +/- need for UDS before surgery @MarcusDrakeUrol #EAU23

Histologic outcomes in #activesurveillance by baseline and change in MRI ⁦@mrsprostate⁩ #eau23

ProtecT 15 yr: ⁦@Freddie_Hamdy⁩ taking on misconceptions, and conclusions. #eau23 Thoughts #pcsm??

Comprehensive overview of PSMA for prostate ca diagnosis @DrMHofman. Strong data from PRIMARY and more to come from PRIMARY2 @gu_onc @declangmurphy #EAU23

The study found a robust benefit to routinely changing gloves & instruments before abdominal wound closure. The authors suggest this routine should be widely implemented into surgical practice around the world. Read the study to find out more:

Very proud to present the ARNEO study published in @EUplatinum!! In high-risk PCa patients, neoadjuvant degarelix plus apalutamide prior to RP results in significantly improved pathological response compared to degarelix alone! @joniau A thread🧵👇: